Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XIII Medicinal Products
Joint committee decision (JCD)
068/2001 In force in the EEA
Yes Legal documents
Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products
Reglugerð Evrópuþingsins og ráðsins (EB) nr. 141/2000 frá 16. desember 1999 um lyf við fágætum sjúkdómum
Verordnung (EG) Nr. 141/2000 des Europäischen Parlaments und des Rates vom 16. Dezember 1999 über Arzneimittel für seltene Leiden
Europaparlaments- og rådsforordning (EF) nr. 141/2000 av 16. desember 1999 om legemidler mot sjeldne sykdommer
History
20.06.2001
Adopted JCD confirmed entry into force date
20.06.2001
Compliance date in the EEA
19.06.2001
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
24.04.2001
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
16.12.1999
Adoption date in the EU
22.01.2000
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.